文献速递慢性肾脏病血液净化与透析

透析患者高危慢性肾脏病-矿物质骨异常表型的识别:历史队列研究

Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

结果显示东欧和南美国家CKD-MBD控制较差,多种表型与死亡和住院风险升高相关,相对死亡风险HR从1.07至1.59,复合终点风险HR从1.07至1.36。

要点

  • 27种互斥CKD-MBD表型中,PTH/Ca/P为LTL者死亡风险最高(HR=1.59)。
  • 东欧和南美国家CKD-MBD控制较西欧差(患病率比0.79,P<0.001)。
  • 多种表型与住院-free生存期缩短和死亡风险增加相关。

核心结论

  • 识别出多种与无住院生存期缩短和死亡风险增加相关的CKD-MBD表型。
  • 相对风险估计或超额事件的排序有助于医疗优先事项的设定。

研究设计与样本

  • 基于PTH、磷、钙6个月均值(低、达标、高)组合定义27种互斥CKD-MBD表型,随访5年。
  • 采用结局风险评分校正的比例风险回归分析表型与5年死亡和住院风险的关联。

主要发现

  • 复合终点发生率为280.0事件/1000人年(95%CI 276.6-283.5)。
  • 东欧和南美国家CKD-MBD控制较西欧差(患病率比0.79;P<0.001)。
  • 完全校正模型中,相对死亡风险HR从1.07(PTH/Ca/P:TLT)至1.59(PTH/Ca/P:LTL);复合终点风险HR从1.07(PTH/Ca/P:TTH)至1.36(PTH/Ca/P:LTL)。

临床怎么用

  • 可通过PTH、磷、钙6个月均值组合识别高危CKD-MBD表型,辅助风险分层。
  • 对高危表型(如LTL)患者可考虑加强监测和干预。
  • 东欧和南美地区需关注CKD-MBD控制不佳的问题。

局限性

  • 历史队列研究设计可能存在残余混杂。
  • 仅纳入EuCliD注册的血液透析患者,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical management of chronic kidney disease-mineral bone disorder (CKD-MBD) remains extremely challenging, partially due to difficulties in defining high-risk phenotypes based on serum biomarkers. We evaluated the prevalence and outcomes of 27 mutually exclusive CKD-MBD phenotypes in a large, multi-national cohort of chronic dialysis patients over a 5-year follow-up study. METHODS: In this historical cohort study, we enrolled all haemodialysis patients registered in EuCliD® on 1 July 2011 across 28 Europe, the Middle East and Africa (EMEA) and South American countries. We created 27 mutually exclusive phenotypes based on combinations of serum parathyroid hormone (PTH), phosphorus (P) and calcium (Ca) 6-month averages (L, low; T, target; H, high). We tested the association between CKD-MBD phenotypes and 5-year mortality and hospitalization risk by outcome risk score-adjusted proportional hazard regression. RESULTS: We enrolled 35 721 eligible patients. Eastern European and South American countries generally achieved poorer CKD-MBD control when compared with Western European countries (prevalence ratio: 0.79; P < 0.001). There were 15 795 deaths [126.7 deaths/1000 person-years; 95% confidence interval (CI) 124.7-128.7]; 18 014 had at least one hospitalization (203.9 hospitalizations/1000 person-years; 95% CI 201.0-206.9); the incidence of the composite endpoint was 280.0 events/1000 person-years (95% CI 276.6-283.5). In the fully adjusted model, relative mortality risk ranged from hazard ratio (HR) = 1.07 (PTH/Ca/P: TLT) to HR = 1.59 (PTH/Ca/P: LTL), whereas the relative composite endpoint risk ranged from HR = 1.07 (PTH/Ca/P: TTH) to HR = 1.36 (PTH/Ca/P: LTL). CONCLUSION: We identified several CKD-MBD phenotypes associated with reduced hospitalization-free survival and increased mortality. Ranking of relative risk estimates or excess events concurs in informing healthcare priority setting.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Neri L, Kreuzberg U, Bellocchio F, et al. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study. Nephrol Dial Transplant. 2019. PMID: 30165528. doi:10.1093/ndt/gfy273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。